AbbVie Inc.


Updates from The Motley Fool

Latest updates on AbbVie from Fool.com.  The Fool has written over 500 articles on AbbVie.
3 Healthcare Value Stocks

It might be hard to find value-priced healthcare stocks, but Gilead Sciences, Masimo, and AbbVie ...

3 Top Stocks Billionaires Love

Two tech stocks and one biotech stock rank near the top of the list for billionaire investors.



Stock Performance

View Interactive ABBV Charts
Sponsored by

Key Data Points

Primary metrics and data points about AbbVie.
Current Price: $97.45
Prev Close: $96.30
Open: $96.86
Bid: $97.19
Ask: $97.93
Day's Range: $96.64 - $97.88
52wk Range: $59.27 - $98.87
Volume: 11,563,963
Avg Vol 4,755,564
Market Cap: $156B
P/E (ttm): 18.14
EPS (ttm): $5.31
Div & Yield: $2.84 (2.9%)

Company Rating

What our community thinks about AbbVie.
CAPS Rating 4 out of 5
 
427 Outperform
10 Underperform
CAPS All Stars
 
87 Outperform
3 Underperform

How do you think AbbVie will perform against the market?



You pick for AbbVie is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Richard A. Gonzalez, CEO

86% Approve

Based on 313 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AbbVie.

AbbVie Inc.

  • Exchange: NYSE